Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.37
+0.11 (1.19%)
At close: Aug 31, 2026, 4:00 PM EDT
9.47
+0.10 (1.07%)
After-hours: Aug 31, 2026, 7:59 PM EDT
Novavax Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 413.8 | 1,123 | 682.16 | 983.71 | 1,982 | 1,146 | |
Revenue Growth | -61.64% | 64.69% | -30.65% | -50.37% | 72.89% | 141.02% |
Cost of Revenue | 424.38 | 409.86 | 590.51 | 1,078 | 2,071 | 2,535 |
Gross Profit | -10.58 | 713.62 | 91.65 | -94.77 | -89.48 | -1,388 |
Selling, General & Admin | 108.8 | 150.38 | 323.59 | 457.45 | 488.69 | 298.36 |
Research & Development | - | - | - | - | 66.57 | - |
Operating Expenses | 108.8 | 150.38 | 323.59 | 457.45 | 555.26 | 298.36 |
Operating Income | -119.38 | 563.24 | -231.93 | -552.21 | -644.74 | -1,687 |
Interest Expense | -22.97 | -22.55 | -20.08 | -14.42 | -19.88 | -21.13 |
Interest & Investment Income | - | 0.03 | 0.04 | 0.02 | - | - |
Currency Exchange Gain (Loss) | -8.7 | -16.7 | -4.4 | 7.9 | -2.5 | -5.3 |
Other Non Operating Income (Expenses) | 53.99 | 57.3 | 44.8 | 29.98 | 13.47 | -1.53 |
EBT Excluding Unusual Items | -97.06 | 581.33 | -211.56 | -528.73 | -653.65 | -1,715 |
Merger & Restructuring Charges | -16.9 | -12.6 | -17 | -14.3 | - | - |
Gain (Loss) on Sale of Assets | -97.85 | -97.85 | 51.95 | - | - | - |
Other Unusual Items | -33.51 | -28.71 | - | - | - | - |
Pretax Income | -245.32 | 442.17 | -176.62 | -543.03 | -653.65 | -1,715 |
Income Tax Expense | 2.42 | 1.87 | 10.88 | 2.03 | 4.29 | 29.22 |
Net Income | -247.73 | 440.3 | -187.5 | -545.06 | -657.94 | -1,744 |
Net Income to Common | -247.73 | 440.3 | -187.5 | -545.06 | -657.94 | -1,744 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 163 | 162 | 152 | 101 | 78 | 74 |
Shares Outstanding (Diluted) | 163 | 173 | 152 | 101 | 78 | 74 |
Shares Change | -3.06% | 13.74% | 51.03% | 28.89% | 5.08% | 29.27% |
EPS (Basic) | -1.52 | 2.72 | -1.23 | -5.41 | -8.42 | -23.44 |
EPS (Diluted) | -1.52 | 2.58 | -1.23 | -5.41 | -8.42 | -23.44 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -42.2 | -250.2 | -100.32 | -767.74 | -504.99 | 268.45 |
Free Cash Flow Per Share | -0.26 | -1.45 | -0.66 | -7.62 | -6.46 | 3.61 |
Gross Margin | -2.56% | 63.52% | 13.44% | -9.63% | -4.52% | -121.10% |
Operating Margin | -28.85% | 50.13% | -34.00% | -56.14% | -32.53% | -147.13% |
Profit Margin | -59.87% | 39.19% | -27.49% | -55.41% | -33.20% | -152.12% |
Free Cash Flow Margin | -10.20% | -22.27% | -14.71% | -78.05% | -25.48% | 23.42% |
EBITDA | -101.55 | 590.85 | -183.44 | -510.99 | -615.68 | -1,674 |
EBITDA Margin | -24.54% | 52.59% | -26.89% | -51.94% | -31.07% | -146.03% |
D&A For EBITDA | 17.83 | 27.61 | 48.5 | 41.23 | 29.05 | 12.66 |
EBIT | -119.38 | 563.24 | -231.93 | -552.21 | -644.74 | -1,687 |
EBIT Margin | -28.85% | 50.13% | -34.00% | -56.14% | -32.53% | -147.13% |
Effective Tax Rate | - | 0.42% | - | - | - | - |
Revenue as Reported | 413.8 | 1,123 | 682.16 | 983.71 | 1,982 | 1,146 |
Advertising Expenses | - | 1.9 | 33.7 | 91.5 | 84 | 8.9 |